Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer
机构：[1]Sichuan Univ, West China Hosp, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China四川大学华西医院[2]State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China[3]Canc Hosp Yunnan Prov, Dept Med Oncol, Kunming, Peoples R China[4]Second Renmin Hosp Yibin City, Dept Med Oncol, Yibin, Peoples R China[5]Kunming Med Univ,Affiliated Hosp 1,Dept Thorac Surg,Kunming,Peoples R China昆明医科大学附属第一医院外科科室胸外科
第一作者机构：[1]Sichuan Univ, West China Hosp, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China[2]State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
推荐引用方式(GB/T 7714)：
Gong Y.,Ren L.,Huang M.,et al.Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer[J].EUROPEAN JOURNAL OF CANCER.2013,49:S828-S828.
APA：
Gong, Y.,Ren, L.,Huang, M.,Li, L.,Peng, F....&Lu, Y..(2013).Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer.EUROPEAN JOURNAL OF CANCER,49,
MLA：
Gong, Y.,et al."Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer".EUROPEAN JOURNAL OF CANCER 49.(2013):S828-S828
医学